PRONKJEWAIL · Protecting patients with enhanced susceptibility to infections
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2016-09-01 → 2021-08-31
- EU contribution
- €1,674,240
- Participants
- 27
- Scheme
- MSCA-COFUND
Lines connect the coordinator with its partners.
Results in brief
Protecting patients with enhanced susceptibility to infections
The Microbes in Health and Disease research programme at the University Medical Center Groningen (UMCG) proposed the Doctoral Training Programme PRONKJEWAIL (‘a real gem’) in the field of hospital care and infection. The specific training objective is ‘protecting patients with enhanced susceptibility to infections’. PRONKJEWAIL recruited 16 international PhD students, who were trained in research, transferable skills, and network and capacity building. They were guided by experienced supervisors from the departments of Medical Microbiology, Internal Medicine, Intensive Care, Clinical Pharmacy and Pharmacology, Paediatrics, Surgery, Cell Biology, and Pharmacoepidemiology and Pharmacoeconomics at the UMCG. 26 partner organisations, including 14 private sector partners, were committed to support ESR training via mentoring, courses and secondments. Research training built on four Pillars: 1) vaccines and primary prevention; 2) personalized detection and infection prevention; 3) iatrogenic influence on the microbiome and 4) personalized therapy/stewardship. Each Pillar integrated fundamental, translational and clinical/epidemiological training projects. The high exposure to fundamental, translational and clinical research in academia and industry increased the PhD students’ problem-solving capabilities. Further, PhD students learned to value mobility through internships at international partner organizations. The scientific results obtained by the PhD students have impact on hospital care and contribute to enhanced public health. By providing excellent training, PRONKJEWAIL developed new talent within the next generation of medical researchers thereby strengthening the European Research Area. Conclusions The Doctoral Training Programme PRONKJEWAIL has achieved the goals proposed. The focus on educating the next generation of European researchers has involved formal training, teamwork within the project through joint scientific projects between ESRs, and performing research in international teams generating 89 scientific articles written so far with organisations and companies across Europe and the world, offering ESRs the skills, knowledge, and networks in order to advance their careers and to continue contributing to the field of infectious diseases. The emphasis on patients with susceptibility to infections has become more relevant with the advent of the COVID-19 pandemic and Pronkjewail ESRs have seamlessly pivoted their work and training to reflect the new reality. The attention given during the project for cultural and work integration, quality of life, and work-life balance, whilst challenging ESRs to achieve excellence in their preferred academic field resulted in a successful project, with ESRs reporting satisfaction with their environment and all choosing to continue a career in research.
Data: CORDIS, © European Union
Project objective
The Microbes in Health and Disease research programme at the University Medical Center Groningen (UMCG) proposes the Doctoral Training Programme PRONKJEWAIL (‘a real gem’) in the field of hospital care and infection. The specific training objective is ‘protecting patients with enhanced susceptibility to infections’. PRONKJEWAIL will recruit 16 international ESRs, who will be trained in research, transferable skills, and network and capacity building. They will be guided by experienced supervisors from the departments of Medical Microbiology, Internal Medicine, Intensive Care, Clinical Pharmacy and Pharmacology, Rheumatology and Immunology, Surgery, Cell Biology, and Pharmacoepidemiology and Pharmacoeconomics at the UMCG. 26 partner organisations, including 14 private sector partners, are committed to support ESR training via mentoring, courses and secondments. Research training builds on four Pillars: 1) vaccines and primary prevention; 2) personalized detection and infection prevention; 3) iatrogenic influence on the microbiome and 4) personalized therapy/stewardship. Each Pillar integrates fundamental, translational and clinical/epidemiological training projects. The high exposure to fundamental, translational and clinical research in academia and industry will increase the ESRs future problem-solving capabilities.Further, ESRs will learn to value mobility through internships at international partner organizations. By providing an excellent scientific working environment PRONKJEWAIL will directly impact on hospital care and, ultimately, it will contribute to enhanced public health. By providing excellent training, PRONKJEWAIL will develop new talent within the next generation of medical researchers thereby strengthening the European Research Area.
Original text from CORDIS.
Participants
- ACADEMISCH ZIEKENHUIS GRONINGEN · GroningenCoordinatorNetherlands
- CHR. HANSEN AS · HORSHOLMDenmark
- COPAN ITALIA SPA · BresciaItaly
- Compagnie Check Points · ParisFrance
- DANONE GLOBAL RESEARCH & INNOVATION CENTER BV · UtrechtNetherlands
- EDINBURGH MOLECULAR IMAGING LIMITED · EdinburghUnited Kingdom
- ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON · ATHINAGreece
- GILEAD SCIENCES INC · Foster City CaUnited States
- Institute of Photonic Technology Leibniz · LeibnizGermany
- Integrated Disease Management Corporation bv · AMSTERDAMNetherlands
- JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG · WuerzburgGermany
- KAROLINSKA INSTITUTET · STOCKHOLMSweden
- KING'S COLLEGE LONDON · LondonUnited Kingdom
- Labhelp International BV · BLADELNetherlands
- MAD multimedia · GRONINGENNetherlands
- MSD BV · HAARLEMNetherlands
- QUEEN MARGARET UNIVERSITY, EDINBURGH · Musselburgh East LothianUnited Kingdom
- STICHTING WETSUS, EUROPEAN CENTRE OF EXCELLENCE FOR SUSTAINABLE WATER TECHNOLOGY · LeeuwardenNetherlands
- THE UNIVERSITY OF ADELAIDE · AdelaideAustralia
- THE UNIVERSITY OF LIVERPOOL · LIVERPOOLUnited Kingdom
- ThermoFisher Scientific · BREDANetherlands
- UCB celltech pharmaceuticals · SloughUnited Kingdom
- UNIVERSIDAD LA SALLE AC · CIUDAD DE MEXICOMexico
- UNIVERSITAETSKLINIKUM TUEBINGEN · TUEBINGENGermany
- UNIVERSITETET I BERGEN · BergenNorway
- University Chest Clinic Lasi · IașiRomania
- VISMEDERI SRL · Siena SiItaly
Links
Data: CORDIS, © European Union